2型糖尿病患者糖化血红蛋白变异性与不良结局风险:大型初级保健队列研究
该研究基于英国初级保健数据,纳入58,832例2型糖尿病患者,估算2006-2009年HbA1c平均值、变异性(变异系数)和轨迹,分析2010-2015年死亡和急诊住院风险。结果显示HbA1c变异性与全因死亡呈一致剂量反应关系,最不稳定组(前10%)死亡风险几乎是最稳定组(后10%)的两倍(HR 1.93,95%CI 1.72-2.16),该关联不能被低血糖解释;仅冠心病和缺血性卒中住院由平均HbA1c而非变异性预测。
要点
- HbA1c变异性与全因死亡和急诊住院风险独立相关,平均水平和轨迹不能完全解释。
- 最不稳定组(前10%)较最稳定组(后10%)死亡风险几乎翻倍(HR 1.93,95%CI 1.72-2.16)。
- 冠心病和缺血性卒中住院仅与平均HbA1c相关,与变异性无关。
核心结论
- HbA1c变异性与全因死亡和急诊住院强烈相关,且不能由平均HbA1c或低血糖事件解释。
- 仅冠心病和缺血性卒中住院与平均HbA1c相关,与变异性无关。
- 糖尿病管理目标应同时关注HbA1c的稳定性和绝对水平。
研究设计与样本
- 基于英国初级保健数据的回顾性队列研究,纳入58,832例2型糖尿病患者。
- 2006-2009年估算HbA1c平均值(年度均值)、变异性(变异系数)和轨迹(年度回归斜率)。
- 2010-2015年随访死亡和急诊住院,采用Cox回归调整年龄、性别、吸烟、BMI、糖尿病病程和贫困程度。
主要发现
- 在互相调整模型中,HbA1c变异性与全因死亡呈一致剂量反应关系。
- HbA1c平均水平仅在分布最高或最低10%的人群中有重要意义,轨迹无独立效应。
- 最不稳定组(前10%)较最稳定组(后10%)死亡风险几乎翻倍(HR 1.93,95%CI 1.72-2.16)。
- 低血糖事件可减弱但不能解释变异性与死亡的关联。
- 急诊住院呈现相似趋势,但冠心病和缺血性卒中住院由平均HbA1c而非变异性预测。
关键数值与推荐
- HbA1c最不稳定组(前10%)与最稳定组(后10%)相比,全因死亡HR为1.93(95%CI 1.72-2.16)。
- HbA1c平均水平仅在最高或最低10%分布人群中具有预测意义。
临床怎么用
- 临床管理2型糖尿病时,除关注HbA1c达标外,应评估并尽量降低HbA1c长期变异性。
- 对于HbA1c波动大的患者,需警惕全因死亡和急诊住院风险增加。
- 预防冠心病和缺血性卒中住院应着重控制平均HbA1c水平。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Diabetes guidelines focus on target glycated hemoglobin (HbA1c) levels. Long-term variability in HbA1c may be predictive of hospitalization or mortality, but its importance at different average levels or trajectories is unclear. RESEARCH DESIGN AND METHODS: Using English primary care data, 58,832 patients with type 2 diabetes had HbA1c average (mean of annual means), variability (coefficient of variation), and trajectory (annual regression slope) estimated during 2006-2009. Hazard ratios (HRs) for mortality and emergency hospitalization during 2010-2015, with adjustment for age, sex, smoking, BMI, duration of diabetes, and deprivation, were estimated using Cox regression. The simultaneous impact of HbA1c average, variability, and trajectory was estimated using percentiles. RESULTS: In mutually adjusted models, HbA1c variability showed a consistent dose-response relationship with all-cause mortality, while average level was only important among individuals in the highest or lowest 10% of the distribution, and trajectory had no independent effect. Individuals with the most unstable HbA1c (top 10%) were almost twice as likely to die (HR 1.93 [95% CI 1.72-2.16]) than were those with the most stable (bottom 10%)-an association attenuated but not explained by hypoglycemia. For emergency hospitalizations, similar trends were seen except for coronary artery disease (CAD) and ischemic stroke (IS), where increasing average rather than variability was predictive. CONCLUSIONS: HbA1c variability was strongly associated with overall mortality and emergency hospitalization and not explained by average HbA1c or hypoglycemic episodes. Only for CAD and IS hospitalizations was no association found, with average HbA1c strongly predictive. Targets should focus on both stability and absolute level of HbA1c.
引用
- Critchley JA, Carey IM, Harris T, et al. Variability in Glycated Hemoglobin and Risk of Poor Outcomes Among People With Type 2 Diabetes in a Large Primary Care Cohort Study. Diabetes Care. 2019. PMID: 31582426. doi:10.2337/dc19-0848
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。